These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25935968)

  • 1. Role of sentinel lymph node biopsy in early breast cancer.
    Patel NS; Sisodia VK; Vadher SH
    J Indian Med Assoc; 2014 Feb; 112(2):110-2. PubMed ID: 25935968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of sentinel lymph node detection by methylene blue and carbon nanoparticle suspension injection in early breast cancer].
    Ge J; Yan B; Cao XC
    Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):226-8. PubMed ID: 21575525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sentinel lymph node biopsy in breast cancer: value for predicting the status of axillary node].
    Su F; Jia W; Li H; Zeng Y; Chen J
    Zhonghua Wai Ke Za Zhi; 2000 Oct; 38(10):784-6. PubMed ID: 11832165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
    Reitsamer R; Peintinger F; Rettenbacher L; Prokop E
    J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
    Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
    J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial experience in a cancer hospital in Nepal with sentinel lymph node mapping and biopsy for evaluation of axillary lymph node status in palpable invasive breast cancer.
    Lamichhane N; Pradhan M; Neupane PR; Shrestha BM; Dhakal HP; Thakur BK; Cox CE
    Nepal Med Coll J; 2007 Mar; 9(1):22-6. PubMed ID: 17593673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The feasibility and the role of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer].
    Péley G; Török K; Farkas E; Mátrai Z; Horváth Z; Sinkovics I; Hitre E; Rényi-Vámos F; Orosz Z; Köves I
    Magy Onkol; 2006; 50(1):19-23. PubMed ID: 16617379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of fine-needle aspiration cytology of axillary lymph nodes in breast cancer patients: a study of 115 cases with cytologic-histologic correlation.
    Alkuwari E; Auger M
    Cancer; 2008 Apr; 114(2):89-93. PubMed ID: 18286535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy.
    Kinoshita T; Takasugi M; Iwamoto E; Akashi-Tanaka S; Fukutomi T; Terui S
    Am J Surg; 2006 Feb; 191(2):225-9. PubMed ID: 16442950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of methylene blue dye for lymphatic basin mapping and sentinel lymph node biopsy in breast cancer patients in Enugu, Nigeria.
    Okoye CL; Ezeome ER
    Niger J Clin Pract; 2022 Nov; 25(11):1805-1811. PubMed ID: 36412286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylene blue dye versus combined dye-radioactive tracer technique for sentinel lymph node localisation in early breast cancer.
    Varghese P; Mostafa A; Abdel-Rahman AT; Akberali S; Gattuso J; Canizales A; Wells CA; Carpenter R
    Eur J Surg Oncol; 2007 Mar; 33(2):147-52. PubMed ID: 17081723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficiency of lymphatic mapping by intradermal injection of vital blue dye for sentinel node identification in T1-2 N0-1 M0 stage breast cancer patients].
    Kokhreidze I; Nemsadze G; Gersamia G; Dzagnidze G; Janjalia M
    Georgian Med News; 2005 Apr; (121):7-10. PubMed ID: 15908713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylene blue dye--a safe and effective alternative for sentinel lymph node localization.
    Varghese P; Abdel-Rahman AT; Akberali S; Mostafa A; Gattuso JM; Carpenter R
    Breast J; 2008; 14(1):61-7. PubMed ID: 18186867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continued axillary sampling is unnecessary and provides no further information to sentinel node biopsy in staging breast cancer.
    Gui GP; Joubert DJ; Reichert R; Ward A; Lakhani S; Osin P; Nerurkar A; A'Hern R; Benson K; Underwood SR
    Eur J Surg Oncol; 2005 Sep; 31(7):707-14. PubMed ID: 15993028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel-node biopsy in axillary lymph-node staging for patients with multicentric breast cancer.
    Schrenk P; Wayand W
    Lancet; 2001 Jan; 357(9250):122. PubMed ID: 11197404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Network for sentinel lymph node research in breast cancer].
    Delaloye JF; Monod JF; Friedli A; Burgener F; Stalder JB; Fiche M; De Grandi P; Delaloye AB
    Rev Med Suisse Romande; 2003 May; 123(5):299-302. PubMed ID: 15095713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blue-dye technique complements four-node sampling for early breast cancer.
    Ishikawa T; Momiyama N; Hamaguchi Y; Tanabe M; Tomita S; Ichikawa Y; Nakatani Y; Sasaki T; Nozawa A; Inayama Y; Inui K; Shimada H
    Eur J Surg Oncol; 2005 Dec; 31(10):1119-24. PubMed ID: 16005597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation.
    Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J
    Ann Surg Oncol; 2008 May; 15(5):1316-21. PubMed ID: 18311507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.